- Issuer ticker
-
SLS
- Reported as of
-
07 Jan 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
09 Jan 2026, 16:30:18 UTC
Filing notes and source
Key filing fact
Jane Wasman filed Form 4 for SELLAS Life Sciences Group, Inc. (SLS) on 09 Jan 2026.
Key facts
- This page summarizes Jane Wasman's Form 4 filing for SELLAS Life Sciences Group, Inc. (SLS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2026, 16:30.
Change
- Previous filing in this sequence was filed on 02 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001352455
Primary reporting owner
Wasman Jane
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- +117%
- Price
-
$0.000000
- Shares after
- 92,900
- Date
- 07 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote